NOTA: ahora el texto se encuentra en el siguiente link:
[ Ссылка ]
Esto permitirá actualizar el texto de forma más eficiente, de ser necesario :) Cálculo del tamaño de muestra y desarrollo del concepto de poder estadístico. Usamos el programa PS: Power and Sample Size Calculation. Además, obtemos la curba de tamaño de muestra vs. poder estadístico.
Carpeta Drive: [ Ссылка ]
El programa usado a lo largo de la serie es R acompañado de RStudio
BIBILIOGRAFÍA DE LA SERIE:
- Arshad AR. Lipid lowering efficacy and safety of atorvastatin and rosuvastatin. 2020. doi:doi/10.7910/DVN/U8NLQC
- Arshad AR. Comparison of Low-Dose Rosuvastatin with Atorvastatin in Lipid-Lowering Efficacy and Safety in a High-Risk Pakistani Cohort: An Open-Label Randomized Trial. J Lipids. 2014;2014:1-5. doi:10.1155/2014/875907
- Geier DA, Kern JK, Geier MR. Increased risk for an atypical autism diagnosis following Thimerosal-containing vaccine exposure in the United States: A prospective longitudinal case-control study in the Vaccine Safety Datalink. J Trace Elem Med Biol. 2017;42:18-24. doi:10.1016/j.jtemb.2017.03.005
- Li Y-X, Bai Z, Long D-J, et al. Predicting the success of vaginal birth after caesarean delivery: a retrospective cohort study in China. BMJ Open. 2019;9(5):e027807. doi:10.1136/bmjopen-2018-027807
- Kesmodel US. Cross-sectional studies - what are they good for? Acta Obstet Gynecol Scand. 2018;97(4):388-393. doi:10.1111/aogs.13331
- Prel J-B du, Hommel G, Röhrig B, Blettner M. Confidence Interval or P-Value? Part 4 of a Series on Evaluation of Scientific Publications. Dtsch Aerzteblatt Online. May 2009. doi:10.3238/arztebl.2009.0335
- Max Roser, Hannah Ritchie, Esteban Ortiz-Ospina and Joe Hasell (2020) - "Coronavirus Pandemic (COVID-19)". Published online at OurWorldInData.org. Retrieved from: '[ Ссылка ]' [Online Resource]
- Dupont WD, Plummer WD: 'Power and Sample Size Calculations: A Review and Computer Program', Controlled Clinical Trials 1990; 11:116-28.
- Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.
